$8.23
▲ +$0.00
(+0.00%)
Vol 147K
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$121.8M
D/E
0.00
Beta
2.55
52W
$9–$10
Price Chart
Quarterly Revenue & Earnings
| Quarter | 2024-1… | 2025-0… | 2025-1… |
|---|---|---|---|
| Revenue | — | — | — |
| Net Income | -$43K | -$20K | $515K |
Fundamentals Trend
| Metric | 2025-07-31 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | — | — | — | — | — |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | — | — | — | 0.00 | 0.00 |
| Current Ratio | 4.62 | — | — | — | 4.62 | 4.62 |
Key Ratios
52W High
$10.19
52W Low
$8.98
$8.98
52-Week Range
$10.19
Financial Health
Free Cash Flow
-$368K
Cash
$220
As of Oct 31, 2025
How does PELI compare to N/A peers?
Peer group: Micro-cap N/A (All) · 453 companies
PELI valuation vs N/A peers
P/E ratio
—
▼
0%
below
peers
(56.5)
vs Peers
vs Industry
Fair value
P/S ratio
—
▼
0%
below
peers
(6.0)
vs Peers
vs Industry
Undervalued
P/B ratio
—
▼
0%
below
peers
(1.3)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(19.6%)
vs Peers
vs Industry
Low yield
PELI profitability vs N/A peers
ROE
—
▼
0%
below
peers
(2.8%)
vs Peers
vs Industry
In line
Net margin
—
▼
0%
below
peers
(0.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼
0%
below
peers
(63.5%)
vs Peers
vs Industry
Weak
ROA
—
▼
0%
below
peers
(2.6%)
vs Peers
vs Industry
In line
PELI financial health vs N/A peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
4.6
▲
309%
above
peers
(1.1)
vs Peers
vs Industry
Below avg
Beta
2.6
▲
12669%
above
peers
(0.0)
vs Peers
vs Industry
More volatile
PELI fundamentals radar
PELI
Peer median
Industry
PELI profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
PELI vs peers: key metrics
Top Holders
Top 5: 21.46%Meteora Capital, LLC
6.26%
$6.2M
Berkley W R Corp
4.82%
$4.8M
Glazer Capital LLC
4.13%
$4.1M
Decagon Asset Management LLP
3.17%
$3.1M
Polar Asset Management Part…
3.08%
$3.0M
As of Dec 31, 2025
Latest News
Hormuz Bypasses Maxed Out: Saudi East-West Pipeline Hits Record 7 MMb/d, As …
ZeroHedge · Mar 28
Clover Corporation CEO on strong H1 results & product pipeline - ASX …
Yahoo Finance · Mar 27
Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline
CNBC · Mar 25
The Saudi Oil Pipeline the World Didn’t Know It Needed
Yahoo Finance · Mar 22
ENAVATE's Zenas Bio Pharma add Is a Footnote — The Obexelimab Pipeline …
Nasdaq · Mar 21